Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosisFotini Vogiatzi, Denis M. Schewe|Blood Advances|2022Cited by 20
Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In VivoDorothee Winterberg, Denis M. Schewe|Journal of Clinical Medicine|2021Cited by 10